Listed by the USPTO as ORTEGA, MARTIN NATHAN
Tech Center 3700 • Art Units: 3791
This examiner grants 27% of resolved cases
ORTEGA, MARTIN NATHAN works in tech center 3700 and art unit 3791. The record contains 82 resolved cases, a 26.8% allowance rate, and a median of 1445 days to allowance. Interview lift is 32.8%, showing a positive association between interviews and allowance outcomes. The limited case volume means the figures should be used cautiously, but the combination identifies interviews as a potentially useful prosecution tool.
The principal companies are Abbott Laboratories, Samsung Electronics Co., Ltd., and Apple Inc. The listed firms are STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., ARENTFOX SCHIFF LLP, and BOOTH UDALL, PLC. The low allowance rate supports early development of claim alternatives and a careful review of the cited art. The 1445-day median makes long-term docket planning important, even where an interview may help narrow the issues.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17900678 | Adjustment or Weighting of Blood Pressure in Response to One or More Biophysical or Environmental Conditions | Final Rejection | Apple Inc. |
| 19003007 | ANALYTE SENSORS AND SENSING METHODS FOR DUAL DETECTION OF GLUCOSE AND ETHANOL | Non-Final OA | Abbott Diabetes Care Inc. |
| 18456951 | SYSTEM, APPARATUS, AND DEVICES FOR ANALYTE MONITORING | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17556923 | SYSTEMS AND METHODS FOR ANALYTE DETECTION | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17478447 | DIGITAL AND USER INTERFACES FOR ANALYTE MONITORING SYSTEMS | Non-Final OA | ABBOTT DIABETES CARE INC. |
| 17309197 | PHYSICAL FITNESS TRAINING SYSTEMS AND METHODS | Non-Final OA | Abbott Diabetes Care Inc. |
| 18015620 | INTRALUMINAL PHYSIOLOGY SENSING DEVICE WITH EMBEDDED CONFORMAL CONDUCTORS | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 17633749 | Neurofeedback Training to Promote Sharp Wave Ripples | Final Rejection | The Regents of the University of California |
| 16962479 | IN-SITU SWEAT RATE MONITORING FOR NORMALIZATION OF SWEAT ANALYTE CONCENTRATIONS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19094722 | Systems and Methods for Predictive Glucose Management | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18077846 | SYSTEMS AND METHODS FOR POWERING AUTONOMOUS SWEAT SENSOR | Non-Final OA | California Institute of Technology |
| 18960126 | COMPRESSION EVENT DETECTION FOR CONTINUOUS GLUCOSE MONITORS | Non-Final OA | Dexcom, Inc. |
| 17821902 | HYPOTENSION PREDICTION WITH ADJUSTABLE HYPOTENSION THRESHOLD | Non-Final OA | Becton, Dickinson and Company |
| 17445915 | SYSTEM AND METHOD FOR CONCUSSIVE IMPACT MONITORING | Non-Final OA | New York University |
| 18042253 | A METHOD AND DEVICE FOR PROVIDING AN AUTOMATED PREDICTION OF A CHANGE OF A STATE OF FATIGUE OF A SUBJECT CARRYING OUT A VISUAL TASK | Non-Final OA | Essilor International |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy26.8% of resolved applications examined by Martin Nathan Ortega were allowed (82 resolved cases), compared with 53.3% across Art Unit 3791 over the last five years.
This examiner's interview lift is +32.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Martin Nathan Ortega took 1,445 days on average from filing to allowance.
Martin Nathan Ortega examines applications in Art Unit 3791 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
